Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chattem Dexatrim, pHisoderm, Icy Hot Extensions Shipping In Coming Months

This article was originally published in The Tan Sheet

Executive Summary

Chattem is gearing up to launch a slew of product line extensions in the next few months as its decision to increase its investment in R&D over the past two years begins to pay dividends

You may also be interested in...



Chattem R&D

Mid-November completion of firm's $2 mil., 10,000 sq. ft. R&D facility in Chattanooga, Tenn. was about three weeks ahead of schedule, Chattem says (1"The Tan Sheet" Jan. 20, 2003, In Brief). In line with increased R&D efforts over the past two years, the firm is set to launch BullFrog Mosquito Coast, which combines sun screen with insect repellent and is designed to last six to eight hours (2"The Tan Sheet" Sept. 22, 2003, p. 4)...

Chattem R&D

Mid-November completion of firm's $2 mil., 10,000 sq. ft. R&D facility in Chattanooga, Tenn. was about three weeks ahead of schedule, Chattem says (1"The Tan Sheet" Jan. 20, 2003, In Brief). In line with increased R&D efforts over the past two years, the firm is set to launch BullFrog Mosquito Coast, which combines sun screen with insect repellent and is designed to last six to eight hours (2"The Tan Sheet" Sept. 22, 2003, p. 4)...

Pfizer BenGay Extension Challenges P&G In Topical Pain Patch Arena

A man strips off breakaway pants on a fashion runway to reveal Pfizer's new BenGay Pain Relieving Patch in national television spots, which broke Oct. 20

Related Content

Topics

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel